PV pharm branch, vendor, cage 0U9U0

Ended Awarded Last action

Contract number
SPE2D826F14TL
Awardee
Awarding agency
Obligated
$102,470

Award facts

Contract value 100% obligated
$102,470.40 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $102,470.40 to AmerSourceBergen Drug Corp on January 21, 2026, with an ultimate completion date of January 22, 2026. This competitively awarded, firm fixed-price delivery order was issued under a larger Indefinite Delivery Contract vehicle and carries no set-aside designation. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving critical federal medical procurement needs for military and veteran healthcare systems. The company supplies a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains.

This delivery order is executed under AmerSourceBergen Drug Corp's significant IDC with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. The parent company, Cencora, Inc., also holds a larger IDC with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. These contract vehicles enable flexible pharmaceutical and medical supply deliveries to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contracting strategy reflects DLA's intent to establish multiple awards for the Pharmaceutical Prime Vendor Global Program Generation V contracts across separate regions, positioning AmerSourceBergen as a critical vendor in the federal medical supply chain.

Quick answers

Who was awarded contract SPE2D826F14TL?

SPE2D826F14TL was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 21, 2026.

How much is contract SPE2D826F14TL worth?

The government has obligated $102,470 on SPE2D826F14TL.

Is contract SPE2D826F14TL an order under another contract?

Yes. SPE2D826F14TL is a delivery order under SPE2DX22D0029, an indefinite delivery contract.

Was contract SPE2D826F14TL competed?

The extent of competition for SPE2D826F14TL was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award